BARDA awards $483m to scale production of Moderna’s COVID vaccine
With recruitment for Phase I trials complete, Moderna receives funds to expand manufacturing capacity ready for late-stage trials.
Archives for April 17, 2020
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs